专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

81. 发明授权

US09140981B2 Actinic-ray-sensitive or radiation-sensitive resin composition, and resist film using the same, pattern forming method, electronic device manufacturing method, and electronic device, each using the same 有权
标题翻译：光敏感或辐射敏感性树脂组合物，使用其的抗蚀剂膜，图案形成方法，电子器件制造方法和电子器件，各自使用它们
公开(公告)号：US09140981B2
公开(公告)日：2015-09-22
申请号：US13614797
申请日：2012-09-13
申请人： Kaoru Iwato , Hidenori Takahashi , Michihiro Shirakawa
发明人： Kaoru Iwato , Hidenori Takahashi , Michihiro Shirakawa
IPC分类号： G03F7/004 , G03F7/38 , C07D327/10 , C07C303/32 , C07C309/04 , C07C309/06 , C07C309/12 , C07C309/17 , C07C309/19 , C07C309/24 , G03F7/038 , G03F7/039 , B32B3/10 , G03F7/20
CPC分类号： G03F7/0045 , B32B3/10 , C07C303/32 , C07C309/04 , C07C309/06 , C07C309/12 , C07C309/17 , C07C309/19 , C07C309/24 , C07D327/10 , G03F7/0046 , G03F7/038 , G03F7/0382 , G03F7/0397 , G03F7/11 , G03F7/20 , G03F7/2041 , G03F7/325 , G03F7/38 , Y10T428/24802
摘要： Provided are an actinic-ray-sensitive or a radiation-sensitive resin composition with greater residual film ratio and capable of suppressing pattern collapse and an occurrence of bridge defects after development, and a resist film, a pattern forming method, an electronic device manufacturing method, and an electronic device, each using the same. An actinic-ray-sensitive or radiation-sensitive resin composition includes a resin (P) having a repeating unit (a) represented by following General Formula (I), a compound (B) represented by any of following General Formulae (B-1) to (B-3), and a solvent, in General Formula (I), R0 represents a hydrogen atom or a methyl group, and R1, R2 and R3 each independently represent a straight chain or branched alkyl group.
摘要翻译：本发明提供了具有更大的残留膜比并且能够抑制图案塌陷和显影后的桥缺陷的发生的光化学敏感性或辐射敏感性树脂组合物，以及抗蚀剂膜，图案形成方法，电子器件制造方法，以及各自使用的电子设备。光化射线敏感性或辐射敏感性树脂组合物包含具有下述通式（I）表示的重复单元（a）的树脂（P），下述通式（B-1））至（B-3），和通式（I）中的R 0表示氢原子或甲基的溶剂，R 1，R 2和R 3各自独立地表示直链或支链烷基。

82. 发明申请

US20150182534A1 OXATHIAZINE DERIVATIVES AS ANTIBACTERIAL AND ANTICANCER AGENTS 有权
标题翻译：作为抗生素和抗原药剂的氧化氮衍生物
公开(公告)号：US20150182534A1
公开(公告)日：2015-07-02
申请号：US14409352
申请日：2013-06-17
申请人： GEISTLICH PHARMA AG
发明人： Rolf W. Pfirrmann
IPC分类号： A61K31/54 , C07D327/10 , A61K31/39 , C07D291/06 , A61K45/06
CPC分类号： A61K31/549 , A61K9/0053 , A61K31/39 , A61K31/54 , A61K31/541 , A61K45/06 , C07D291/06 , C07D327/10 , C07D419/06 , Y02A50/473
摘要： New oxathiazin-like compounds and their derivatives are useful as antineoplastic and antimicrobial agents.
摘要翻译：新的噻唑嗪类化合物及其衍生物可用作抗肿瘤和抗微生物剂。

83. 发明授权

US09051248B2 Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid 有权
标题翻译：用于递送1,3-丙二磺酸的方法，化合物和组合物
公开(公告)号：US09051248B2
公开(公告)日：2015-06-09
申请号：US13389606
申请日：2010-08-06
申请人： Xianqi Kong , Nigel Levens , Abderrahim Bouzide , Stephane Ciblat , Richard Frenette , Johanne Renaud
发明人： Xianqi Kong , Nigel Levens , Abderrahim Bouzide , Stephane Ciblat , Richard Frenette , Johanne Renaud
IPC分类号： C07C309/65 , C07D319/06 , A61K31/366 , A61K31/365 , A61K31/255 , C07D309/22 , A61K31/351 , C07C309/05 , C07C311/06 , C07C311/51 , C07D213/64 , C07D213/65 , C07D231/12 , C07D307/33 , C07D307/58 , C07D307/77 , C07D327/10 , C07F9/09 , C07F9/40
CPC分类号： C07C309/65 , A61K31/255 , A61K31/351 , A61K31/365 , A61K31/366 , C07C309/05 , C07C311/06 , C07C311/51 , C07C2601/04 , C07C2601/14 , C07D213/64 , C07D213/65 , C07D231/12 , C07D307/00 , C07D307/33 , C07D307/58 , C07D307/77 , C07D309/22 , C07D319/06 , C07D327/00 , C07D327/10 , C07F9/091 , C07F9/4006 , C07F9/4043
摘要： The invention relates to methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid (1,3PDS) in a subject, preferably a human subject. The invention encompasses compounds that will yield or generate 1,3PDS, either in vitro or in vivo. The invention also relates to sulfonate ester prodrugs of 1,3PDS as well as Gemini dimmers and oligomers of 1,3PDS for the prevention or treatment of associated diseases and conditions.
摘要翻译：本发明涉及在受试者，优选人受试者中递送1,3-丙二磺酸（1,3PDS）的方法，化合物和组合物。本发明包括在体外或体内产生或产生1,3PDS的化合物。本发明还涉及1,3PDS的磺酸酯前药以及用于预防或治疗相关疾病和病症的1,3PDS的双子座二聚体和寡聚体。

84. 发明授权

US08933108B2 Benzothiazolone compound 有权
标题翻译：苯并噻唑酮化合物
公开(公告)号：US08933108B2
公开(公告)日：2015-01-13
申请号：US13603990
申请日：2012-09-05
申请人： Jun Cao , Bernhard Erb , Robin Alec Fairhurst , Arnaud Grandeury , Shinji Hatakeyama , Magdalena Koziczak-Holbro , Xinzhong Lai , Philipp Lustenberger , Bernd Riebesehl , Nicola Tufilli , Thomas Ullrich , Xiang Wu , Jianguang Zhou
发明人： Jun Cao , Bernhard Erb , Robin Alec Fairhurst , Arnaud Grandeury , Shinji Hatakeyama , Magdalena Koziczak-Holbro , Xinzhong Lai , Philipp Lustenberger , Bernd Riebesehl , Nicola Tufilli , Thomas Ullrich , Xiang Wu , Jianguang Zhou
IPC分类号： A01N43/78 , A61K31/425 , C07D277/62 , C07D277/68 , C07D327/04 , C07D343/00 , C07D327/10 , C07D339/02 , C07D341/00 , C07D409/00 , C07D411/00 , C07D495/00 , C07D497/00 , A61K31/428 , A61K45/06
CPC分类号： A61K31/428 , A61K31/167 , A61K45/06 , C07B2200/07 , C07C53/10 , C07D277/68 , Y02P20/55
摘要： The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions.
摘要翻译：本发明提供游离形式或药学上可接受的盐形式的式（I）化合物，其制备本发明化合物的方法及其治疗用途。本发明还提供药理活性剂和药物组合物的组合。

85. 发明申请

US20130004862A1 NONAQUEOUS ELECTROLYTE SOLUTION, ELECTROCHEMICAL ELEMENT USING SAME, AND 1,2-DIOXYPROPANE COMPOUND USED IN SAME 有权
标题翻译：非电解电解质溶液，使用它们的电化学元素和使用于其中的1,2-二氧戊环化合物
公开(公告)号：US20130004862A1
公开(公告)日：2013-01-03
申请号：US13634006
申请日：2011-03-24
申请人： Kazuhiro Miyoshi , Yuichi Kotou , Shoji Shikita
发明人： Kazuhiro Miyoshi , Yuichi Kotou , Shoji Shikita
IPC分类号： H01M10/056 , H01G9/00 , C07D327/10 , C07D317/36 , H01G9/035 , H01G9/038
CPC分类号： H01M10/0567 , C07D317/18 , C07D317/38 , C07D327/10 , C07D497/04 , C07F9/65742 , H01M4/131 , H01M4/386 , H01M4/387 , H01M4/52 , H01M4/5825 , H01M4/587 , H01M10/052 , H01M10/0569 , H01M2300/0037 , Y02E60/122 , Y02T10/7011
摘要： An object of the present invention is to provide a nonaqueous electrolytic solution capable of improving low-temperature load characteristics after high temperature charging storage, an electrochemical element using it, and a 1,2-dioxypropane compound used for it.The nonaqueous electrolytic solution of the present invention comprises an electrolyte salt dissolved in a nonaqueous solvent, and contains a 1,2-dioxypropane compound represented by the above-mentioned general formula (I). (wherein R1 and R2 each represent a hydrogen atom, or an alkyl group having from 1 to 6 carbon atoms; X1 represents a group selected from —S(═O)—, —S(═O)2—, —C(═O)—, —CR3R4—, —P(═O)(OR5)— and —SiR6R7—; R3 and R4 each represent a hydrogen atom, or an alkyl group having from 1 to 6 carbon atoms; R5 to R7 each represent an alkyl group having from 1 to 6 carbon atoms. Y1 represents an alkylsulfinyl group, an alkenylsulfinyl group, an alkynylsulfinyl group, an arylsulfinyl group, an alkylsulfonyl group, an alkenylsulfonyl group, an alkynylsulfonyl group, or an arylsulfonyl group; Z1 represents a hydrogen atom, an alkyl group, an alkylsulfinylmethyl group, an alkenylsulfinylmethyl group, an alkynylsulfinylmethyl group, an arylsulfinylmethyl group, an alkylsulfonylmethyl group, an alkenylsulfonylmethyl group, an alkynylsulfonylmethyl group, or an arylsulfonylmethyl group; provided that at least one hydrogen atom on the carbon atom of X1, Y1 and Z1 may be substituted with a halogen atom).
摘要翻译：本发明的目的是提供一种能够提高高温充电保存后的低温负荷特性的非水电解液，使用它的电化学元件和用于其的1,2-二氧代丙烷化合物。本发明的非水电解液包含溶解在非水溶剂中的电解质盐，并含有上述通式（I）表示的1,2-二氧代丙烷化合物。（其中R 1和R 2各自表示氢原子或具有1至6个碳原子的烷基; X 1表示选自-S（= O） - ， - S（= O）2 - ， - C（= O） - ， - CR 3 R 4 - ， - P（= O）（OR 5） - 和-SiR 6 R 7 - ; R 3和R 4各自表示氢原子或具有1至6个碳原子的烷基; 具有1至6个碳原子的烷基，Y1表示烷基亚磺酰基，烯基亚磺酰基，炔基亚磺酰基，芳基亚磺酰基，烷基磺酰基，链烯基磺酰基，炔基磺酰基或芳基磺酰基; Z1表示氢原子烷基，烷基亚磺酰基甲基，烯基亚磺酰基甲基，炔基亚磺酰基甲基，芳基亚磺酰基甲基，烷基磺酰基甲基，链烯基磺酰基甲基，炔基磺酰基甲基或芳基磺酰基甲基;条件是：至少一个碳原子上的氢原子 X1，Y1和Z1可以是不同的用卤素原子）。

86. 发明授权

US07368567B2 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists 失效
标题翻译：芳基磺酰基苯并二氧杂环己烷，苯并恶嗪和苯并噻嗪类作为5-HT6拮抗剂
公开(公告)号：US07368567B2
公开(公告)日：2008-05-06
申请号：US11121873
申请日：2005-05-04
申请人： Jacob Berger , Shu-Hai Zhao
发明人： Jacob Berger , Shu-Hai Zhao
IPC分类号： C07D265/36 , C07D498/02 , C07D321/00 , C07D323/00 , C07D327/06 , C07D327/10 , C07D339/08 , C07D341/00 , C07D343/00 , C07D409/00 , C07D411/00 , C07D495/00
CPC分类号： C07D319/20 , C07D405/06
摘要： Compounds of the formula I: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein m, n, p, Ar, X, R1, R2, R3, R4, R5 and R6 are as defined herein. Also provided are compositions comprising, methods of preparing, and methods of using the subject compounds.
摘要翻译：式I化合物或其药学上可接受的盐，溶剂合物或前药，其中m，n，p，Ar，X，R 1，R 2，R R 3，R 4，R 5和R 6如本文所定义。还提供了包含，制备方法和使用本发明化合物的方法的组合物。

87. 发明申请

US20030181511A1 Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid 失效
标题翻译：二氢噻吩并萘甲酰胍：组合物，制备方法和用作药物或诊断助剂
公开(公告)号：US20030181511A1
公开(公告)日：2003-09-25
申请号：US10350520
申请日：2003-01-23
发明人： Heinz-Werner Kleemann , Peter Below
IPC分类号： C07D327/10 , A61K031/382
CPC分类号： C07D335/10
摘要： Dihydrothiaphenanthrenecarbonylguanidine compound of formula I 1 These compounds are potentially suitable as antiarrythmic medicaments with a cardioprotective component for prophylaxis of an infarction and treatment of infarction, and for treatment of angina pectoris. They may also inhibit in a preventive manner the pathophysiological processes involved in the development of ischemia-induced damage, especially in the initiation of ischemia-induced cardiac arrhythmias.
摘要翻译：式I的二氢噻吩并萘羰基胍化合物这些化合物潜在地适合作为具有用于预防梗死和治疗梗塞以及用于治疗心绞痛的心脏保护组分的抗焦虑药物。它们还可以以预防的方式抑制涉及缺血诱导的损伤发展的病理生理过程，特别是在引发缺血诱发的心律失常中。

88. 发明授权

US6084107A Intermediates for making HIV-protease inhibitors 失效
标题翻译：制备HIV-蛋白酶抑制剂的中间体
公开(公告)号：US6084107A
公开(公告)日：2000-07-04
申请号：US923942
申请日：1997-09-05
申请人： Srinivasan Babu , Bennett C. Borer , Travis P. Remarchuk , Robert J. Szendroi , Kathleen R. Whitten , Juliette K. Busse , Kim F. Albizati
发明人： Srinivasan Babu , Bennett C. Borer , Travis P. Remarchuk , Robert J. Szendroi , Kathleen R. Whitten , Juliette K. Busse , Kim F. Albizati
IPC分类号： C07C309/73 , C07D209/48 , C07D327/10 , C07D209/36 , C07D305/02 , C07D327/04
CPC分类号： C07D209/48 , C07C309/73 , C07D327/10
摘要： HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.
摘要翻译： HIV蛋白酶抑制剂抑制或阻断HIV蛋白酶的生物学活性，导致HIV病毒的复制终止。这些化合物可以通过使用本发明新颖的中间体的本发明的新方法来制备。

89. 发明授权

US5705647A Intermediates for making HIV-protease inhibitors 失效
公开(公告)号：US5705647A
公开(公告)日：1998-01-06
申请号：US708607
申请日：1996-09-05
申请人： Srinivasan Babu , Bennett C. Borer , Travis P. Remarchuk , Robert J. Szendroi , Kathleen R. Whitten , Juliette K. Busse , Kim F. Albizati
发明人： Srinivasan Babu , Bennett C. Borer , Travis P. Remarchuk , Robert J. Szendroi , Kathleen R. Whitten , Juliette K. Busse , Kim F. Albizati
IPC分类号： C07D327/10 , A61K31/421 , A61K31/472 , A61P31/18 , C07C303/30 , C07C309/65 , C07C309/72 , C07D209/48 , C07D217/26 , C07D233/22 , C07D263/14 , C07D401/06 , C07D413/04 , C07D413/06 , C07D401/02 , C07D233/04
CPC分类号： C07D233/22 , C07D413/04 , C07D413/06
摘要： HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.

90. 发明授权

US5516566A Cyclic oligomers for production of linear polyketones, polyphthalazines and polyisoquinolines 失效
标题翻译：用于生产线性聚酮，多酞嗪和聚异喹啉的环状低聚物
公开(公告)号：US5516566A
公开(公告)日：1996-05-14
申请号：US367584
申请日：1995-01-03
申请人： Allan S. Hay , Kwok P. Chan
发明人： Allan S. Hay , Kwok P. Chan
IPC分类号： C07D321/00 , C07D323/00 , C07D327/00 , C07D327/10 , C07D498/08 , B29D23/00 , C07D498/00 , C08G10/00
CPC分类号： C07D321/00 , C07D323/00 , C07D327/00 , C07D327/10 , Y10T428/1352 , Y10T428/1362 , Y10T428/1369 , Y10T428/1372 , Y10T428/139
摘要： Low molecular weight cyclic oligomers of formula (I) ##STR1## in which n is an integer of 2 to 20, and each C in the oligomer is a radical of formula (II): ##STR2## and each X in the oligomer is --O--R--O-- or --S--R--S--, B and D are both carbonyl groups CO, or together represent a divalent radical of formula ##STR3## in which A.sub.1, A.sub.2, A.sub.3 A.sub.4, Ar.sub.1, Ar.sub.2 and Ar.sub.3 are selected from a variety of aromatic radicals, A.sub.1, A.sub.2, Ar.sub.3 and Ar.sub.4 also possibly being hydrogen, are useful in the production of high molecular weight, linear, polyketones, polyphthalazines and polyisoquinolines; the cyclic oligomers have low melt viscosities when heated above their softening temperatures and can be readily molded, whereafter they can be ring-open polymerized to form molded high molecular weight polymer products with excellent properties.
摘要翻译：（I）的低分子量环状低聚物，其中n为2至20的整数，低聚物中的每个C为式（II）的基团：每个低聚物中的X是-ORO-或-SRS-，B和D都是羰基CO，或者一起代表式为“IMAGE”的二价基团，其中A1，A2，A3A4，Ar1，Ar2和Ar3选自各种芳基，A1，A2，Ar3和Ar4也可能是氢，可用于生产高分子量，线性，聚酮，多酞嗪和聚异喹啉; 环状低聚物在其软化温度以上加热时具有低熔融粘度，并且可以容易地模塑，然后它们可以开环聚合以形成具有优异性能的模制高分子量聚合物产品。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式